Home > Boards > US Listed > Biotechs > Aravive - Oncology/Biotech Company (ARAV)

initial 10K shares purchased @ $7.20 yesterday upon

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
iDeVos Member Profile
 
Followed By 1
Posts 28
Boards Moderated 0
Alias Born 02/07/19
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/5/2020 6:04:39 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/3/2020 4:16:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2020 4:11:35 PM
Aravive Reports Second Quarter 2020 Financial Results and Provides Recent Corporate Updates GlobeNewswire Inc. - 8/3/2020 4:01:10 PM
Aravive to Participate in Upcoming Virtual Investor Conferences in August GlobeNewswire Inc. - 7/30/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2020 7:06:46 AM
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500 in Platinum Resistant Ovarian Cancer GlobeNewswire Inc. - 7/23/2020 7:00:10 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 7/14/2020 4:06:33 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/14/2020 8:19:52 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 7/2/2020 4:23:53 PM
Aravive Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire Inc. - 6/30/2020 4:05:10 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/29/2020 6:06:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 4:06:43 PM
Aravive To Present at The 2020 RBC Capital Markets Global Healthcare Conference GlobeNewswire Inc. - 5/12/2020 8:00:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 4:19:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:12:05 PM
Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates GlobeNewswire Inc. - 5/6/2020 4:05:10 PM
Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer... GlobeNewswire Inc. - 4/30/2020 8:00:10 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 4/16/2020 6:02:41 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/10/2020 4:30:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2020 4:44:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:11:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:08:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:06:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:06:16 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist